You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4926 to 4950 of about 5861
Next 25
03/02/2005
Parents face choice in treating childhood cancer
03/01/2005
Myriad Initiates Phase 1 Trial of MPC-6827 in Metastatic Brain Cancer
02/28/2005
Breaking News - FDA Clears Oncolytics Brain-Tumor Trial
YM BioSciences and Oncoscience Report Response Rate of 35.3% in Pediatric Glioma - TheraCIM h-R3 (nimotuzumab) Phase II Results Presented at European High Grade Glioma Conference -
Chugai Pharmaceutical`s Antitumor Agent Natulan Now Available for Treating Glioma 28 Feb 2005
02/27/2005
15 Kilometer Run Benefits Brain Tumor Charities (Long Island, NY)
02/23/2005
Selective excision of metastatic brain tumors originating in the motor cortex with preservation of function.
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
Parathyroid Adenoma Linked to Primary CNS Tumors
Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases.
High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
02/22/2005
Added Link to: www.artofthebrain.org
Added Link to: UCLA Neuro-Oncology Program:
02/20/2005
Weary Canadians Skate to Ice Hockey Record
02/19/2005
Researchers Search for Causes of Brain Cancer National Brain Tumor Foundation sponsors groundbreaking international research consortium in search for causes of brain tumors.
02/18/2005
Researchers identify target for cancer drugs
Book: Brain Tumors - Leaving The Garden OF Eden - Interview of the author - Dr Paul Zeltzer
02/15/2005
Dr. S. R. Burzynski Gives Presentation at ICACT in Paris
A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors.
Tamoxifen-induced cell death and expression of neurotrophic factors in cultured C6 glioma cells.
Ganglioside GM3 inhibits proliferation and invasion of glioma.
UCLA Neuro-Oncology Program & Kaiser Permanente-LA NeuroOncology Program are hosting the 5th Annual Brain Tumor Conference on March 18th and 19th at the UCLA Bradley International Hall.
Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance.
Increased resistance of glioma cell lines to extracellular ATP cytotoxicity.
Radiation dosimetry of (131)I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.